JP2012092144A5 - - Google Patents

Download PDF

Info

Publication number
JP2012092144A5
JP2012092144A5 JP2012022511A JP2012022511A JP2012092144A5 JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5 JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012022511 A JP2012022511 A JP 2012022511A JP 2012092144 A5 JP2012092144 A5 JP 2012092144A5
Authority
JP
Japan
Prior art keywords
cell
test substance
psgl
cells
contacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012022511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012092144A (ja
Filing date
Publication date
Priority claimed from US10/051,497 external-priority patent/US7744888B2/en
Application filed filed Critical
Publication of JP2012092144A publication Critical patent/JP2012092144A/ja
Publication of JP2012092144A5 publication Critical patent/JP2012092144A5/ja
Pending legal-status Critical Current

Links

JP2012022511A 2001-08-03 2012-02-03 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター Pending JP2012092144A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31019601P 2001-08-03 2001-08-03
US60/310,196 2001-08-03
US10/051,497 2002-01-18
US10/051,497 US7744888B2 (en) 2001-08-03 2002-01-18 Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008058501A Division JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Publications (2)

Publication Number Publication Date
JP2012092144A JP2012092144A (ja) 2012-05-17
JP2012092144A5 true JP2012092144A5 (https=) 2013-06-06

Family

ID=26729479

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2012022511A Pending JP2012092144A (ja) 2001-08-03 2012-02-03 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2003518607A Expired - Fee Related JP4815101B2 (ja) 2001-08-03 2002-03-13 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター
JP2008058501A Abandoned JP2008260759A (ja) 2001-08-03 2008-03-07 Ｐ−セレクチン糖タンパク質リガンド１のモジュレーター

Country Status (19)

Country Link
US (3) US7744888B2 (https=)
EP (2) EP1411982B1 (https=)
JP (3) JP4815101B2 (https=)
KR (1) KR100850731B1 (https=)
CN (2) CN101045161B (https=)
AT (2) ATE411045T1 (https=)
AU (1) AU2002305041B2 (https=)
CA (1) CA2428822C (https=)
CY (2) CY1108701T1 (https=)
DE (1) DE60229394D1 (https=)
DK (2) DK1985634T3 (https=)
ES (2) ES2316569T3 (https=)
IL (4) IL160168A0 (https=)
MX (1) MXPA04001047A (https=)
NO (2) NO333456B1 (https=)
NZ (1) NZ531199A (https=)
PT (2) PT1985634E (https=)
TW (1) TWI327070B (https=)
WO (1) WO2003013603A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
BRPI0414402A (pt) * 2003-09-15 2006-11-14 Abgenomics Corp moduladores de ligante 1 de glicoproteìna p-selectina
EP1689776A2 (en) * 2003-11-12 2006-08-16 Wisconsin Alumni Research Foundation Equine p-selectin glycoprotein ligand-1 and uses thereof
UY28886A1 (es) * 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
AU2012201999C1 (en) * 2004-05-10 2016-05-12 Abgenomics Cooperatief U.A. Antibodies
ES2655833T3 (es) * 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
WO2007033959A2 (en) * 2005-09-19 2007-03-29 Vib Vzw Use of p-selectin glycoprotein ligand 1 in modulation of hematogenous metastasis of lymphomas
US20070160601A1 (en) * 2005-12-09 2007-07-12 Angela Widom Neutralizing antibodies against primate psgl-1 and uses therefor
US7833530B2 (en) * 2008-05-15 2010-11-16 Selexys Pharmaceuticals Corporation Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies
ES2387156B1 (es) * 2010-12-01 2013-07-04 Universidad Autónoma de Madrid Uso de psgl-1 para el tratamiento de enfermedades inflamatorias y autoinmunes
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF
PT3166636T (pt) 2014-07-08 2021-06-29 Sanford Burnham Med Res Inst Moduladores de psgl-1 e utilizações dos mesmos
IL260289B (en) 2016-01-08 2022-08-01 Bioalliance Cv Tetravalent anti-psgl-1 antibodies and uses thereof
US20170241415A1 (en) * 2016-02-19 2017-08-24 Muzan, Inc. Sanitary check valve
KR20250159733A (ko) 2017-01-11 2025-11-11 브리스톨-마이어스 스큅 컴퍼니 Psgl-1 길항제 및 그의 용도
PE20250933A1 (es) 2017-03-14 2025-04-02 Five Prime Therapeutics Inc Anticuerpos de union a vista a ph acido
BR112020019083A2 (pt) 2018-03-21 2020-12-29 Five Prime Therapeutics, Inc. Anticorpos, ácido nucleico, composições, célula e métodos para preparar um anticorpo, para tratar câncer, para tratar uma doença infecciosa, para tratar uma inflamação, para a identificação de um anticorpo, para melhorar a eficácia antitumoral de um anticorpo, para melhorar a farmacocinética de um anticorpo, para selecionar um anticorpo, para melhorar a eficácia de anticorpos, para isolar anticorpos, para detectar vista em uma amostra e para tratar câncer
PE20210687A1 (es) 2018-07-11 2021-04-08 Bristol Myers Squibb Co Anticuerpos de union a vista a ph acido
CN112740043A (zh) 2018-07-20 2021-04-30 皮埃尔法布雷医药公司 Vista受体
WO2020224450A1 (en) * 2019-05-03 2020-11-12 The University Of Hong Kong Method for peritoneal metastatic cell detection and isolation thereof
CA3141334A1 (en) 2019-06-04 2020-12-10 Verseau Therapeutics, Inc. Anti-psgl-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof
WO2025168211A1 (en) * 2023-02-10 2025-08-14 Novo Nordisk A/S P-selectin peptide ligands

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4704692A (en) 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5464778A (en) * 1989-03-08 1995-11-07 Board Of Regents Of The University Of Oklahoma Glycoprotein ligand for P-selectin and methods of use thereof
US5378464A (en) * 1989-03-08 1995-01-03 Board Of Regents Of The University Of Oklahoma Modulation of inflammatory responses by administration of GMP-140 or antibody to GMP-140
US5690933A (en) * 1989-05-31 1997-11-25 Glaxo Wellcome Inc. Monoclonal antibodies for inducing tolerance
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5709859A (en) * 1991-01-24 1998-01-20 Bristol-Myers Squibb Company Mixed specificity fusion proteins
US6124267A (en) * 1991-02-05 2000-09-26 Southpac Trust Internationals, Inc. O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
US6309639B1 (en) * 1991-02-05 2001-10-30 The Board Of Regents Of The University Of Oklahoma Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
US5972625A (en) * 1991-05-06 1999-10-26 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
US5843707A (en) * 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
WO1994014836A1 (en) * 1992-12-18 1994-07-07 Centocor, Inc. Peptide inhibitors of selectin binding
DE69415154T2 (de) * 1993-01-25 1999-07-29 Dana-Farber Cancer Institute, Inc., Boston, Mass. Chimäre selektine erhältlich durch domänenaustauch und ihre verwendungen
WO1995014787A1 (en) * 1993-11-22 1995-06-01 Centocor, Inc. Peptide inhibitors of selecting binding
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
KR100523506B1 (en) 1995-08-03 2005-10-24 Peptide and O-glycan inhibitors of selectin mediated inflammation
JPH09227410A (ja) 1996-02-21 1997-09-02 Sumitomo Pharmaceut Co Ltd 臓器移植拒絶反応の抑制剤
WO1999043353A2 (en) * 1998-02-26 1999-09-02 Boehringer Ingelheim Pharmaceuticals, Inc. Combination anti-selectin and immunosuppressant therapy
CA2347119A1 (en) 1998-10-30 2000-05-11 Genetics Institute, Inc. Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
US20040002450A1 (en) * 2000-12-29 2004-01-01 Janette Lazarovits Y17 - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
EP1406930A4 (en) 2000-12-29 2007-01-10 Savient Pharmaceuticals Inc "ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
US20040001839A1 (en) * 2000-12-29 2004-01-01 Avigdor Levanon Multimers - isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
US7744888B2 (en) 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
US20050152906A1 (en) * 2003-06-30 2005-07-14 Avigdor Levanon Specific human antibodies
UY28886A1 (es) 2004-05-10 2005-12-30 Boehringer Ingelheim Int Anticuerpos que consisten en polipéptidos y derivados conprendiendo tres secuencias conteniendo respectivamente los siguientes números de seq. id: 1-3 y 4-6; 7-9 y 10-12 y 13-15 ó 16-18
ES2655833T3 (es) 2004-05-11 2018-02-21 AbGenomics Coöperatief U.A. Epítopos que inducen la muerte de células T
EP2718325A4 (en) 2011-06-13 2015-03-11 ABGENOMICS COöPERATIEF U A ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

Similar Documents

Publication Publication Date Title
JP2012092144A5 (https=)
NZ711723A (en) Microfluidic devices and methods for use thereof in multicellular assays of secretion
MX2015012823A (es) Ensayo de combinacion de antigeno-anticuerpo del virus de la hepatitis c (vhc) y metodos y composiciones para usarlo.
MX389472B (es) Inmunoensayo que utiliza un conjugado de captura
MX2017005750A (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso.
WO2019105468A8 (en) Methods for using cd137 ligand as a biomarker for treatment with anti-cd137 antibody
HK1223943A1 (zh) 嵌合的靶向抗原受体的单克隆抗体
HUE052011T2 (hu) CD3 elleni ellenanyagok, CD123 elleni ellenanyagok és CD3-hoz és/vagy CD123-hoz spedifikusan kötõdõ bispecifikus ellenanyagok
EP2801092A4 (en) METHODS, DEVICES AND COMPUTER PROGRAM PRODUCTS FOR IMPLEMENTING AUTOMATIC LANGUAGE RECOGNITION AND RECEIVING RECOGNITION ON A DEVICE
EP2972348A4 (en) METHOD FOR DETECTING DONATOR-SPECIFIC ANTIBODIES AND SYSTEMS FOR CARRYING OUT THEREOF
TR201904882T4 (tr) Tıbbi kullanım için bispesifik antikorlar.
MX2016005686A (es) Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
AU2011285694A8 (en) Detection of degradation products of canine NT-proBNP
PH12016501339A1 (en) Novel anti-netrin-1 antibody
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
JP2015520378A5 (https=)
WO2015003160A3 (en) Hepatocytes in co-culture and uses thereof
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
WO2014025424A3 (en) Boron-nitrogen-containing acene compounds and their preparation
EP2546266A4 (en) MONOCLONAL ANTIBODY AGAINST THE NEKROSEMARKER ERP29 AND USE THEREOF
SG11201700407QA (en) Frame member-equipped transfer film, biomolecule analysis device, reagent tank, and shaking device
FR2996010B1 (fr) Dispositif de prediction des seismes et des eruptions volcaniques, de localisation des epicentres et des magnitudes par la mesure du radon dans le sol
WO2018176030A3 (en) Antibodies and immunoassays for detection of bmp-15 and gdf-9 isoforms
WO2012158207A3 (en) Method for mutiplexed microfluidic bead-based immunoassay
WO2015069718A3 (en) Pre-haptoglobin-2 monoclonal antibodies and uses thereof